Cerity Partners LLC lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,999 shares of the exchange traded fund’s stock after selling 558 shares during the quarter. Cerity Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,581,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Tidemark LLC lifted its stake in SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares during the last quarter. ORG Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at about $40,000. Quintet Private Bank Europe S.A. bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at about $40,000. ORG Wealth Partners LLC purchased a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at about $44,000. Finally, Howe & Rusling Inc. bought a new position in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $49,000.
SPDR S&P Biotech ETF Stock Performance
XBI stock opened at $99.31 on Tuesday. The firm has a 50 day moving average price of $98.22 and a 200-day moving average price of $96.64. SPDR S&P Biotech ETF has a 52-week low of $77.21 and a 52-week high of $105.47. The firm has a market capitalization of $7.57 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Most active stocks: Dollar volume vs share volume
- How to Master Trading Discipline: Overcome Emotional Challenges
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.